ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

PTGX Protagonist Therapeutics Inc

25.15
0.49 (1.99%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 461,248
Bid Price 24.20
Ask Price 38.15
News -
Day High 25.23

Low
13.72

52 Week Range

High
33.34

Day Low 24.22
Company Name Stock Ticker Symbol Market Type
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.49 1.99% 25.15 20:00:00
Open Price Low Price High Price Close Price Prev Close
24.69 24.22 25.23 25.15 24.66
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,206 461,248 $ 24.96 $ 11,513,593 - 13.72 - 33.34
Last Trade Time Type Quantity Stock Price Currency
17:32:51 priorref 85,700 $ 25.15 USD

Protagonist Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.47B 58.27M - 60M -78.96M -1.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Protagonist Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PTGX Message Board. Create One! See More Posts on PTGX Message Board See More Message Board Posts

Historical PTGX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week25.1127.7824.2225.70401,3960.040.16%
1 Month28.7729.2124.2227.18545,879-3.62-12.58%
3 Months28.4733.3424.2228.18590,097-3.32-11.66%
6 Months14.1833.3413.7524.04702,76910.9777.36%
1 Year23.2133.3413.7223.06805,2591.948.36%
3 Years29.5650.546.9121.03974,835-4.41-14.92%
5 Years9.9950.544.4719.77755,75615.16151.75%

Protagonist Therapeutics Description

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment.

Your Recent History

Delayed Upgrade Clock